Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INCIRWD · Entity 5213 | Director | June 02, 2021 | June 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRONWOOD PHARMACEUTICALS INC
Report date June 02, 2021 · Filed June 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 241,720 |
Reported balance
After 2021-06-02 transaction · row 1
1 source rowRow 1 · 2021-06-02 · Grant · Acquired 22,766 · Balance 241,720 F1: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. |
| Class A Common StockSEC Table I · non-derivative | IndirectThe Owens Family Foundation | 40,000 |
Reported balance
Holding disclosure · report date 2021-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 40,000 F2: The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
F2: The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2021 Filed Jun 4, 2021 20:17 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 22,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038218 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,720 F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:41 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | PurchaseClass A Common Stock | 3,000 | $8.90 | $26,700.00 |
DisclosureSEC source: 0001209191-21-016082 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,954 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.88 to $8.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:15 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | PurchaseClass A Common Stock | 5,000 | $9.11 | $45,550.00 |
DisclosureSEC source: 0001209191-21-014866 · doc4.xml · nonDerivative · entry 2 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,954 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.05 to $9.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | PurchaseClass A Common Stock | 7,000 | $9.26 | $64,820.00 |
DisclosureSEC source: 0001209191-21-014866 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,954 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.19 to $9.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:39 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 21,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034700 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,954 F1 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:18 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 22,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033645 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,234 F1 · kind: The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. Read SEC document |
| August 20, 2018 Filed Aug 24, 2018 21:18 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GiftClass A Common Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048406 · doc4.xml · nonDerivative · entry 2 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Owens Family Foundation Disclosed balance after: 40,000 F1 · ownership.nature: The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities. Read SEC document |
| August 20, 2018 Filed Aug 24, 2018 21:18 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GiftClass A Common Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-048406 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,528 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:30 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 16,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035250 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,528 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 21:03 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037355 · doc4.xml · nonDerivative · entry 1 Owens Edward P · CIK 0001570533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,305 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.